From the Journals

Radiation exposure in MICU may exceed recommended limit

Dr. Nirmal S. Sharma

Dr. Nirmal S. Sharma

Nirmal Sharma, MD, comments: This is a very valid study. I think radiation exposure in the ICU is too high. Previous studies have shown that doing imaging on demand has had similar outcomes to doing it daily. (Currently, across the country, chest x-rays are done daily for most patients in the ICU, who have a respiratory problem.) We tried using this model at the University of Alabama at Birmingham, but some physicians were not comfortable with it and had to revert to previous practices. We would need future studies to find out if the radiation exposures in survivors from the ICU results in increased incidence of malignancies at a later date.


 

FROM CHEST

Patients admitted to medical intensive care units may be exposed to doses of radiation that are substantial and exceed federal annual occupational limits, according to results of a recent observational study.

Patient gets a chest x-ray Blend Images/Fotolia
“Although we were unable to assess or predict the potential long-term adverse effects of radiation exposure, judicious use of radiological resources is recommended,” Dr. Krishnan and his colleagues wrote in Chest.

The retrospective, observational study included 4,155 adult admissions to a medical intensive care unit (MICU) at an academic medical center in 2013. Investigators calculated the cumulative effective dose (CED) of radiation based on reported ionizing radiological studies for each patient.

With a median length of stay of just 6.4 days, a total of 131 admissions (3%) accrued a CED of radiation of at least 50 millisieverts (mSv), the annual limit recommended by the National Commission on Radiation Protection, and 47 of those patients (1%) accrued a CED of radiation of at least 100 mSv, the 5-year cumulative exposure limit, the authors reported.

These findings suggest that “MICU patients could be subjected to radiation doses in a matter of days that are equivalent to or more than [the] CED observed in patients with chronic diseases and patients with trauma,” wrote Dr. Krishnan and his coauthors.

As hypothesized, patients with higher severity of illness scores (APACHE III scores) received a higher CED of radiation, according to the report. Using a multivariable linear regression model, investigators found that higher CED was predicted by higher APACHE III scores, sepsis, longer MICU stay, and gastrointestinal disorders and bleeding.

CT scans were the most common source of radiation exposure in patients who exceeded a 50 mSv of radiation, accounting for 49% of the total accrued dose, with interventional radiology accounting for 38%, authors reported.

Despite concerns about “the statistical risk of latent radiogenic cancer,” radiologic studies performed in the critically ill have the potential to reduce morbidity and mortality, the authors acknowledged in a discussion of the results.

“This understandably shifts the risk-benefit ratio towards radiation exposure,” the researchers wrote. “However, complacency in this regard cannot be entirely justified.”

Of the patients in the study who were exposed to a CED of at least 50 mSv, 81% survived the hospital admission and could be subjected to even more radiation as a part of ongoing medical care, they noted.

“Robust tools for monitoring CED prospectively per episode of clinical care, counseling patients exposed to high doses of radiation, and prospective studies exploring radiogenic risk associated with medical radiation are urgently required,” the authors said.

Dr. Krishnan and his coauthors reported no significant conflicts of interest.

SOURCE: Krishnan S et al. Chest. 2018 Feb 4. doi: 10.1016/j.chest.2018.01.019.

Recommended Reading

Three factors linked to rhinovirus pneumonia in HCT patients
MDedge Hematology and Oncology
Hospital infections top WHO’s list of priority pathogens
MDedge Hematology and Oncology
Oral iron of no benefit in heart failure with iron deficiency
MDedge Hematology and Oncology
End-of-life advice: More than 500,000 chat on Medicare’s dime
MDedge Hematology and Oncology
PVC phlebitis rates varied widely, depending on assessment tool
MDedge Hematology and Oncology
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
MDedge Hematology and Oncology
RBCs from previously pregnant women linked to increased mortality in men
MDedge Hematology and Oncology
VIDEO: Rapid influenza test obviates empiric antivirals
MDedge Hematology and Oncology
Red cell age: No impact on mortality after transfusion
MDedge Hematology and Oncology
Lung injury risk higher with apheresis blood products
MDedge Hematology and Oncology